725
Participants
Start Date
April 29, 2013
Primary Completion Date
May 5, 2016
Study Completion Date
January 27, 2017
ABP 980
ABP 980 was administered at an initial dose of 8 mg/kg over a 90-minute intravenous (IV) infusion, then 6 mg/kg IV infusion Q3W for all subsequent cycles.
Trastuzumab
Trastuzumab was administered at an initial dose of 8 mg/kg over a 90-minute IV infusion, then 6 mg/kg IV infusion Q3W for all subsequent cycles.
Paclitaxel
Paclitaxel, 175 mg/m² Q3W for 4 cycles (or 80 mg/m² QW for 12 cycles, if local standard of care).
Lumpectomy or Mastectomy with Sentinel Node or Axillary Node Dissection
Research Site, Budapest
Research Site, Budapest
Research Site, Sofia
Research Site, Johannesburg
Research Site, Debrecen
Research Site, Durban
Research Site, Nyíregyháza
Research Site, Veliko Tarnovo
Research Site, Szolnok
Research Site, Pleven
Research Site, Szekszárd
Research Site, Cape Town
Research Site, Cape Town
Research Site, Varna
Research Site, Belgrade
Research Site, Belgrade
Research Site, Athens
Research Site, Athens
Research Site, Berlin
Research Site, A Coruña
Research Site, Fürstenwalde
Research Site, Niš
Research Site, Milan
Research Site, Varese
Research Site, Kamenitz
Research Site, San Fermo della Battaglia
Research Site, Lleida
Research Site, Madrid
Research Site, Madrid
Research Site, Alcorcón
Research Site, Piacenza
Research Site, Kragujevac
Research Site, Lutsk
Research Site, Parma
Research Site, Bottrop
Research Site, Dnipropetrovsk
Research Site, Toluca, Estado de Mexico
Research Site, Bonn
Research Site, Thessaloniki
Research Site, Chernivtsi
Research Site, Frankfurt am Main
Research Site, Frankfurt am Main
Research Site, Kharkiv
Research Site, Monterrey
Research Site, Zaporizhzhya
Research Site, Heraklion
Research Site, Bari
Research Site, Querétaro
Research Site, San Luis Potosí City
Research Site, Lviv
Research Site, Uzhhorod
Research Site, Palermo
Research Site, Ploieşti
Research Site, Moscow
Research Site, Moscow Region
Research Site, Yaroslavl
Research Site, Arkhangelsk
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Minsk
Research Site, Minsk
Research Site, Brest
Research Site, Grodno
Research Site, Obninsk
Research Site, Timișoara
Research Site, Sochi
Research Site, Pyatigorsk
Research Site, Ryazan
Research Site, Cluj-Napoca
Research Site, Cluj-Napoca
Research Site, Saransk
Research Site, Chelaybinsk
Research Site, Brasov
Research Site, Nizhny Novgorod
Research Site, Temuco
Research Site, Santiago
Research Site, Salvador
Research Site, Ijuí
Research Site, Porto Alegre
Research Site, Jaú
Research Site, Santo André
Research Site, São Paulo
Research Site, Moncton
Research Site, Montreal
Research Site, Poznan
Research Site, Poznan
Research Site, Bydgoszcz
Research Site, Warszawa
Research Site, Warsaw
Research Site, Warsaw
Research Site, Gdansk
Research Site, Rybnik
Research Site, Sabadell
Research Site, Barcelona
Research Site, Kyiv
Research Site, Nottingham
Research Site, Peterborough
Lead Sponsor
Collaborators (1)
Actavis Inc.
INDUSTRY
Amgen
INDUSTRY